TriLink BioTechnologies, a Maravai LifeSciences company, is a world-class CDMO specializing in the synthesis of high-quality nucleic acids, custom oligonucleotides, and mRNA capping technologies (such as CleanCap®). TriLink provides critical raw materials and manufacturing services to support mRNA therapeutics, gene editing workflows, and vaccine development from research through GMP commercial scale.
Subscribe to our newsletter
Subscribe to receive the latest news and innovations straight to your inbox.
Your subscription could not be saved. Please try again.
We use cookies for various purposes including to make your experience of our website better. Please confirm below that you consent to our use of non-essential cookies in accordance with our cookies policy. Click here to access our cookies policy and find out more about our cookie use and how to disable cookies.